Literature DB >> 21270394

Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence.

Ian M Kaplan1, Sebastien Morisot, Diane Heiser, Wen-Chih Cheng, Min Jung Kim, Curt I Civin.   

Abstract

Tristetraprolin (TTP, Zfp36, Nup475, Tis11) dramatically reduces the stability of target mRNAs by binding to AU-rich elements in their 3' untranslated regions. Through this mechanism, TTP functions as a rheostatic, temporal regulator of gene expression. TTP knockout (KO) mice exhibit completely penetrant granulocytic hyperplasia. We have shown that the hematopoietic stem-progenitor cell compartment in TTP KO mice is also altered. Although no change was detected in long-term hematopoietic stem cell (HSC) frequency or function, as assayed by immunophenotypic markers or limiting dilution transplants, we observed increases in the frequencies and numbers of short-term HSCs, multipotent progenitors, and granulocyte-monocyte progenitors. This pattern is consistent with "reactive granulopoiesis," in which committed myeloid progenitors and more primitive progenitors cycle more actively to increase production of mature granulocytes in response to infection or adjuvant. We created reverse chimeras by transplanting wild-type bone marrow into TTP KO mice and found the "reactive granulopoiesis" phenocopied, indicating a non-hematopoietic stem-progenitor cell-autonomous mechanism. Correspondingly, we found elevated levels of the granulopoietic TTP targets IL-1β, TNF-α, and IL-6 in the plasma of TTP KO mice. Consistent with the non-cell-autonomous nature of the phenotype, we found elevated levels of IL-1β, TNF-α, and IL-6 transcripts in the livers of TTP KO mice and no detectable difference in the bone marrows. These findings demonstrate the importance of TTP in inflammatory homeostasis and highlight the ability of the hematopoietic system to respond to stress without significant numbers of quiescent HSCs entering the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270394      PMCID: PMC3114656          DOI: 10.4049/jimmunol.1002806

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability.

Authors:  E Carballo; W S Lai; P J Blackshear
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.

Authors:  Anne Wilson; Elisa Laurenti; Gabriela Oser; Richard C van der Wath; William Blanco-Bose; Maike Jaworski; Sandra Offner; Cyrille F Dunant; Leonid Eshkind; Ernesto Bockamp; Pietro Lió; H Robson Macdonald; Andreas Trumpp
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

Authors:  T R Ulich; J del Castillo; K Z Guo
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

4.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

5.  Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.

Authors:  J L Christensen; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.

Authors:  D E Wright; S H Cheshier; A J Wagers; T D Randall; J L Christensen; I L Weissman
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

7.  "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection.

Authors:  S Basu; G Hodgson; H H Zhang; M Katz; C Quilici; A R Dunn
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

8.  Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay.

Authors:  Jin-Yu Lu; Robert J Schneider
Journal:  J Biol Chem       Date:  2004-01-07       Impact factor: 5.157

9.  The Wnt/beta-catenin-->Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs.

Authors:  Paola Briata; Cristina Ilengo; Giorgio Corte; Christoph Moroni; Michael G Rosenfeld; Ching-Yi Chen; Roberto Gherzi
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

10.  Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression.

Authors:  Yoshihiro Ueda; Kaiyong Yang; Sandra J Foster; Motonari Kondo; Garnett Kelsoe
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more
  15 in total

Review 1.  An Ancient Family of RNA-Binding Proteins: Still Important!

Authors:  Melissa L Wells; Lalith Perera; Perry J Blackshear
Journal:  Trends Biochem Sci       Date:  2017-01-14       Impact factor: 13.807

2.  Deficiency of GRP94 in the hematopoietic system alters proliferation regulators in hematopoietic stem cells.

Authors:  Biquan Luo; Chun-Chih Tseng; Gregor B Adams; Amy S Lee
Journal:  Stem Cells Dev       Date:  2013-08-20       Impact factor: 3.272

3.  Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype.

Authors:  Lian-Qun Qiu; Deborah J Stumpo; Perry J Blackshear
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

4.  The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome.

Authors:  Moritz Haneklaus; John D O'Neil; Andrew R Clark; Seth L Masters; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2017-03-16       Impact factor: 5.157

Review 5.  Exploring the RNA world in hematopoietic cells through the lens of RNA-binding proteins.

Authors:  Joan Yuan; Stefan A Muljo
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

6.  Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.

Authors:  Sonika Patial; Alan D Curtis; Wi S Lai; Deborah J Stumpo; Georgette D Hill; Gordon P Flake; Mark D Mannie; Perry J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

7.  Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.

Authors:  Wen-Jing Jin; Cai-Feng Chen; Hui-Yu Liao; Lu-Lu Gong; Xiao-Hui Yuan; Bin-Bin Zhao; Ding Zhang; Xia Feng; Jing-Jun Liu; Yu Wang; Guo-Feng Chen; Hui-Ping Yan; You-Wen He
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

8.  ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.

Authors:  Ming-Tai Chen; Lei Dong; Xin-Hua Zhang; Xiao-Lin Yin; Hong-Mei Ning; Chao Shen; Rui Su; Feng Li; Li Song; Yan-Ni Ma; Fang Wang; Hua-Lu Zhao; Jia Yu; Jun-Wu Zhang
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

9.  MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.

Authors:  Valerie A Morris; Ailin Zhang; Taimei Yang; Derek L Stirewalt; Ranjani Ramamurthy; Soheil Meshinchi; Vivian G Oehler
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

10.  Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease.

Authors:  Céline Molle; Tong Zhang; Laure Ysebrant de Lendonck; Cyril Gueydan; Mathieu Andrianne; Félicie Sherer; Gaetan Van Simaeys; Perry J Blackshear; Oberdan Leo; Stanislas Goriely
Journal:  J Exp Med       Date:  2013-08-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.